Hudson Bay Capital Management
IPCI

Hudson Bay Capital Management’s Intellipharmaceuticals International Inc. IPCI Stock Holding History

Hudson Bay Capital Management’s Portfolio IPCI Stock Details IPCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,000
Closed -$28K – 960
2016
Q4 		$28K Hold
1,000
– – ﹤0.01% 607
2016
Q3 		$21K Buy
+1,000
New +$17.9K ﹤0.01% 419

Other funds holding IPCI

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
FFA
First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ATC
Argent Trust Co Nashville, Tennessee $3.46B AUM 30.37% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 10.02% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AG
Advisor Group Phoenix, Arizona $14.5B AUM 28.91% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hudson Bay Capital Management's IPCI Position: Q1 2017 in Review

Hudson Bay Capital Management sold out of Intellipharmaceuticals International Inc. (IPCI) in Q1 2017, closing a stake of 1,000 shares — an estimated $28K sold.

Hudson Bay Capital Management first reported a position in IPCI in Q3 2016 and held it in 2 quarters. The position peaked at $28K in Q4 2016. 22 funds tracked by Wall St. Rank hold IPCI as of Q1 2017.

  • Hudson Bay Capital Management reported no remaining Intellipharmaceuticals International Inc. position as of Q1 2017 after selling out during the quarter.
  • Hudson Bay Capital Management sold 1,000 Intellipharmaceuticals International Inc. shares in Q1 2017, an estimated $28K.
  • Hudson Bay Capital Management first reported a position in Intellipharmaceuticals International Inc. in Q3 2016 and held it in 2 quarters.
  • Hudson Bay Capital Management's Intellipharmaceuticals International Inc. position peaked at $28K in Q4 2016.
  • 22 funds tracked by Wall St. Rank held Intellipharmaceuticals International Inc. as of Q1 2017.

Based on Hudson Bay Capital Management's 13F filing for Q1 2017, filed 15 May 2017.